Metformin could reduce long Covid rates, large study finds
Generic metformin could provide an affordable tool for preventing long Covid when taken at the time of Covid-19 infection.

Generic metformin could provide an affordable tool for preventing long Covid when taken at the time of Covid-19 infection.
CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
The future of long Covid trials
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
Role of machine learning tools in early diagnosis of Parkinson’s disease
Shionogi starts Phase I trial of Covid-19 antiviral in Japan